- Home
- CCU vs IRON Comparison
CCU vs IRON Comparison
Compare CCU & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCU
- IRON
- Stock Information
- Founded
- CCU 1850
- IRON 2017
- Country
- CCU Chile
- IRON United States
- Employees
- CCU N/A
- IRON N/A
- Industry
- CCU Beverages (Production/Distribution)
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- CCU Consumer Staples
- IRON Health Care
- Exchange
- CCU Nasdaq
- IRON Nasdaq
- Market Cap
- CCU 2.2B
- IRON 2.1B
- IPO Year
- CCU 1992
- IRON N/A
- Fundamental
- Price
- CCU $11.67
- IRON $62.63
- Analyst Decision
- CCU Strong Sell
- IRON Strong Buy
- Analyst Count
- CCU 1
- IRON 10
- Target Price
- CCU $10.00
- IRON $97.80
- AVG Volume (30 Days)
- CCU 117.1K
- IRON 290.2K
- Earning Date
- CCU 11-05-2025
- IRON 11-11-2025
- Dividend Yield
- CCU 2.60%
- IRON N/A
- EPS Growth
- CCU 38.53
- IRON N/A
- EPS
- CCU 0.44
- IRON N/A
- Revenue
- CCU $3,254,866,554.00
- IRON N/A
- Revenue This Year
- CCU $10.29
- IRON N/A
- Revenue Next Year
- CCU $4.48
- IRON N/A
- P/E Ratio
- CCU $13.75
- IRON N/A
- Revenue Growth
- CCU 19.82
- IRON N/A
- 52 Week Low
- CCU $10.03
- IRON $30.82
- 52 Week High
- CCU $15.75
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- CCU 39.26
- IRON 62.67
- Support Level
- CCU $11.90
- IRON $59.65
- Resistance Level
- CCU $12.28
- IRON $63.54
- Average True Range (ATR)
- CCU 0.25
- IRON 2.48
- MACD
- CCU -0.03
- IRON 0.04
- Stochastic Oscillator
- CCU 3.49
- IRON 61.97
About CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.